UM  > Faculty of Health Sciences
Residential Collegefalse
Status已發表Published
TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response
Zheng, Mengqi1,2; Zhai, Yunjiao3; Yu, Yanbo1,2,4,5; Shen, Jing3; Chu, Shuzheng3; Focaccia, Enrico6; Tian, Wenyu3; Wang, Sui1; Liu, Xuesong3; Yuan, Xi3; Wang, Yue1; Li, Lixiang1,2,4,5; Feng, Bingcheng1; Li, Zhen1,2,4,5; Guo, Xiaohuan7,14; Qiu, Ju8; Zhang, Cuijuan9,15; Hou, Jiajie10,16; Sun, Yiyuan1; Yang, Xiaoyun1,2,4,5; Zuo, Xiuli1,2,4,5; Heikenwalder, Mathias6,11; Li, Yanqing1,2,4,5; Yuan, Detian12; Li, Shiyang1,2,3,13
2024-09-03
Source PublicationCell Metabolism
ISSN1550-4131
Volume36Issue:9Pages:2086-2103
Other Abstract

SUMMARY

The intestine constantly encounters and adapts to the external environment shaped by diverse dietary nutrients. However, whether and how gut adaptability to dietary challenges is compromised in ulcerative colitis is incompletely understood. Here, we show that a transient high-fat diet exacerbates colitis owing to inflammation-compromised bile acid tolerance. Mechanistically, excessive tumor necrosis factor (TNF) produced at the onset of colitis interferes with bile-acid detoxification through the receptor-interacting serine/threonine-protein kinase 1/extracellular signal-regulated kinase pathway in intestinal epithelial cells, leading to bile acid overload in the endoplasmic reticulum and consequent apoptosis. In line with the synergy of bile acids and TNF in promoting gut epithelial damage, high intestinal bile acids correlate with poor infliximab response, and bile acid clearance improves infliximab efficacy in experimental colitis. This study identifies bile acids as an ‘‘opportunistic pathogenic factor’’ in the gut that would represent a promising target and stratification criterion for ulcerative colitis prevention/therapy. 

KeywordBile Acid Detoxification Infliximab Tumor Necrosis Factor Ulcerative Colitis
DOI10.1016/j.cmet.2024.06.008
URLView the original
Indexed BySCIE
Language英語English
WOS Research AreaCell Biology ; Endocrinology & Metabolism
WOS SubjectCell Biology ; Endocrinology & Metabolism
WOS IDWOS:001306813000001
PublisherCELL PRESS, 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139
Scopus ID2-s2.0-85198577770
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionFaculty of Health Sciences
Cancer Centre
DEPARTMENT OF BIOMEDICAL SCIENCES
Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau
Corresponding AuthorHeikenwalder, Mathias; Li, Yanqing; Yuan, Detian; Li, Shiyang
Affiliation1.Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, 250012, China
2.Shandong Provincial Clinical Research Center for Digestive Diseases, Jinan, China
3.Advanced Medical Research Institute, Shandong University, Jinan, 250012, China
4.Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, 250012, China
5.Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, 250012, China
6.Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
7.Institute for Immunology, School of Medicine, Tsinghua University, Beijing, 100084, China
8.CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China
9.Institute of Pathology and Pathophysiology, Shandong University School of Medicine, Jinan, 250012, China
10.Cancer Centre, Faculty of Health Sciences University of Macau, Macau SAR, China
11.The M3 Research Center, Medical faculty, University Tübingen, Tübingen, Ottfried-Müller Strasse 37, Germany
12.Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shandong University, Jinan, 250012, China
13.Key Laboratory for Experimental Teratology of Ministry of Education, Shandong University, Jinan, 250012, China
14.Beijing Key Laboratory for Immunological Research on Chronic Diseases, Tsinghua University, Beijing, 100084, China
15.Department of Pathology, Qilu Hospital of Shandong University, Jinan, 250012, China
16.MOE Frontier Science Centre for Precision Oncology, University of Macau, Macau SAR, China
Recommended Citation
GB/T 7714
Zheng, Mengqi,Zhai, Yunjiao,Yu, Yanbo,et al. TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response[J]. Cell Metabolism, 2024, 36(9), 2086-2103.
APA Zheng, Mengqi., Zhai, Yunjiao., Yu, Yanbo., Shen, Jing., Chu, Shuzheng., Focaccia, Enrico., Tian, Wenyu., Wang, Sui., Liu, Xuesong., Yuan, Xi., Wang, Yue., Li, Lixiang., Feng, Bingcheng., Li, Zhen., Guo, Xiaohuan., Qiu, Ju., Zhang, Cuijuan., Hou, Jiajie., Sun, Yiyuan., ...& Li, Shiyang (2024). TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response. Cell Metabolism, 36(9), 2086-2103.
MLA Zheng, Mengqi,et al."TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response".Cell Metabolism 36.9(2024):2086-2103.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zheng, Mengqi]'s Articles
[Zhai, Yunjiao]'s Articles
[Yu, Yanbo]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zheng, Mengqi]'s Articles
[Zhai, Yunjiao]'s Articles
[Yu, Yanbo]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zheng, Mengqi]'s Articles
[Zhai, Yunjiao]'s Articles
[Yu, Yanbo]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.